Life science companies, from emerging to evolved, therapeutics to diagnostics, solo or partnered, are constantly fundraising. Each enterprise must make strategic choices along the way about its desired funding composition and timing, target investor mix, and how they build value. In this Expert Class, financing options and successful strategies for young Life Sciences & MedTech companies are being discussed.

The focus is on financing options for biotech and MedTech companies till series A financing round. The topics will be addressed from different perspectives and experts like dilutive non-dilutive financing, term sheets, subsidies and vouchers, tax incentives and convertible loans will be discussed. Also, the involvement of experienced CEO’s and CFO’s in your Management team will be addressed.

Take a look at further information about the event and participation requirements here.